News Releases

News and information from The Leukemia & Lymphoma Society

FDA Approves Second LLS-Supported CAR T-cell Immunotherapy

Rye Brook, N.Y. (October 18, 2017) – The Leukemia & Lymphoma Society (LLS) hails today’s U.S. Food and Drug Administration (FDA) approval of a new, personalized cell therapy that supercharges the patient’s immune system to find and kill cancer cells. The therapy, axicabtagene ciloleucel (Yescarta ™), is the second of this new method of treatment, known as CAR (chimeric antigen receptor) T-cell immunothera...

UFCW AND THE LEUKEMIA & LYMPHOMA SOCIETY ARE UNITED IN THE FIGHT TO END CANCER

Washington D.C. (September 27, 2017) - The United Food and Commercial Workers International Union (UFCW) and The Leukemia & Lymphoma Society (LLS) today announced the launch of Labor Against Cancer, a movement to end the devastation of cancer, led by the passionate members of the UFCW. This new initiative features a fundraising drive among members, retail campaigns, and walking to end cancer with LLS's Light The ...

New Senate Bill Would Put Cancer Care Out of Reach for Many

Rye Brook, N.Y. (September 20, 2017) - U.S. Senators Lindsay Graham (South Carolina) and Bill Cassidy (Louisiana) recently introduced a bill to dismantle portions of the Affordable Care Act. The U.S. Senate may advance this legislation as early as next week under a special process that requires only a simple majority to advance it to the U.S. House of Representatives. The Graham-Cassidy proposal would increase premiu...

Jordin Sparks Joins Burlington Stores And LLS To Fight Blood Cancers

Rye Brook, NY (September 18, 2017) - The Leukemia & Lymphoma Society (LLS) is proud to announce its 16th consecutive year of partnership with Burlington Stores, the national off-price retailer. Joining Burlington and LLS to support the cause for the first time is singer and songwriter Jordin Sparks, an avid activist for cancer research. Each September during Blood Cancer Awareness Mon...

Pages

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: